Technology | Contrast Media Injectors | February 16, 2016

Guerbet Receives FDA 510k Clearance for OptiOne Single-Head Contrast Delivery System

Entry-level injector offers advanced multipurpose functionality for CT imaging procedures

Guerbet, OptiOne single-head contrast delivery system, FDA 510k clearance

February 16, 2016 — Guerbet announced that it has received 510K clearance from the U.S. Food and Drug Administration (FDA) for its OptiOne Single-Head Contrast Delivery System, featuring advanced multipurpose functionality for computed tomography (CT) imaging procedures.

The OptiOne is an entry-level single-head injector launched in 2015 on the European market, available in ceiling-suspended and pedestal form. It is designed for the injection of radiopaque contrast agents in the vascular system of patients to obtain diagnostic images in CT scan examinations.

Guerbet will present the injector at the upcoming European Congress of Radiology (ECR), March 2-6 in Vienna.

The system combines ease of use, multipurpose functionality and optimized contrast media usage. It is designed to be adaptable to the workflow of the imaging department, providing a fully programmable powerhead with intuitive bedside operation and flexibility of use with the ability to accommodate prefilled or empty syringes.

The OptiOne is intended for use by doctors, radiology technologists and other licensed medical practitioners in a healthcare facility or hospital with CT equipment. Each injection is accomplished with a motor-driven syringe mechanism with microprocessor control of the flow rate, volume, pressure and timing. 

OptiOne is manufactured by Cincinnati, Ohio-based Liebel-Flarsheim, a company acquired by Guerbet as part of its purchase of Mallinckrodt's Contrast Media and Delivery Systems business announced on Nov. 27, 2015.

For more information: www.guerbet.com

Related Content

The CT scanner might not come with protocols that are adequate for each hospital situation, so at Phoenix Children’s Hospital they designed their own protocols, said Dianna Bardo, M.D., director of body MR and co-director of the 3D Innovation Lab at Phoenix Children’s.

The CT scanner might not come with protocols that are adequate for each hospital situation, so at Phoenix Children’s Hospital they designed their own protocols, said Dianna Bardo, M.D., director of body MR and co-director of the 3D Innovation Lab at Phoenix Children’s.

Sponsored Content | Case Study | Radiation Dose Management | August 13, 2019
Radiation dose management is central to child patient safety. Medical imaging plays an increasing role in the accurate...
Videos | CT Angiography (CTA) | August 07, 2019
This is a quick walk around of the new Siemens Somatom Go.top cardiovascular edition compact computed tomography (CT)
Videos | CT Angiography (CTA) | August 07, 2019
This is a quick walk around of the GE Healthcare Cardiographe dedicated cardiac CT system on display at the...
Contrast Use in First Transthoracic Echocardiogram for Heart Failure Reduces Repeat Testing
News | Cardiovascular Ultrasound | August 07, 2019
Heart failure is the fourth most common cause for all admission to U.S. hospitals, and it is the most common reason for...
Artificial Intelligence Improves Heart Attack Risk Assessment
News | CT Angiography (CTA) | August 06, 2019
When used with a common heart scan, machine learning, a type of artificial intelligence (AI), does better than...
Montefiore Nyack Hospital Uses Aidoc AI to Spot Urgent Conditions Faster
News | Artificial Intelligence | August 05, 2019
Montefiore Nyack Hospital, an acute care hospital in Rockland County, N.Y., announced it is utilizing artificial...
Bracco Receives FDA Approval for Varibar Thin Liquid for Oral Suspension
Technology | Contrast Media | August 05, 2019
Bracco Diagnostics Inc. announced U.S. Food and Drug Administration (FDA) approval for Varibar Thin Liquid (barium...